Bausch + Lomb Corporation (BLCO)

Market Cap	4.83B
Revenue (ttm)	4.83B
Net Income (ttm)	-362.00M
Shares Out	353.72M
EPS (ttm)	-1.03
PE Ratio	n/a
Forward PE	19.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	375,874
Open	13.90
Previous Close	13.88
Day's Range	13.64 - 13.90
52-Week Range	10.45 - 21.69
Beta	0.62
Analysts	Hold
Price Target	15.83 (+15.89%)
Earnings Date	Jul 30, 2025

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during heal...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 6, 2022
• Employees: 13,300
• Stock Exchange: NYSE
• Ticker Symbol: BLCO
• Website: https://www.bausch.com

Financial Performance

In 2024, Bausch + Lomb's revenue was $4.79 billion, an increase of 15.56% compared to the previous year's $4.15 billion. Losses were -$317.00 million, 21.9% more than in 2023.

Analyst Summary

According to 13 analysts, the average rating for BLCO stock is "Hold." The 12-month stock price target is $15.83, which is an increase of 15.89% from the latest price.

Price Target

$15.83

(15.89% upside)

Analyst Consensus: Hold